hrs4r
 I want to donate

MARGARITA SALA LLINÀS

Firma
MARGARITA SALA-LLINÀS
Position
Investigador/a Consolidat - R3
Established Researchers - R3

Publicacions

0

Outcome of liver cancer patients with SARS-CoV-2 infection.

LIVER INTERNATIONAL, 2022, 42, 1891-1901 dx.doi.org/10.1111/liv.15320

Reig A, Álvarez-Navascués C, Vergara M, Gómez-Domínguez E, Gallego-Moya A, Pérez-Medrano IM, Fábrega E, Hernández-Guerra M, Berenguer M, Estevez P, Arencibia A, Morillas RM, Horta D, Albillos A, Casado M, De la Cruz G, Fernandez-Bonilla E, Molina E, Hijona L, Diago M, Fernández-Rodriguez CM, González-Santiago JM, Sala M, Gómez-Camarero J, Romero-Gomez M, Suárez F, Vargas V, Ferre-Aracil C, Andrade RJ, Chahri N, Parés A

Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study.

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116, 2250-2257 dx.doi.org/10.14309/ajg.0000000000001343

Muñoz-Martínez S, Sapena V, Forner A, Nault JC, Sapisochin G, Rimassa L, Sangro B, Bruix J, Sanduzzi-Zamparelli M, Holówko W, El Kassas M, Mocan T, Bouattour M, Merle P, Hoogwater FJH, Alqahtani SA, Reeves HL, Pinato DJ, Giorgakis E, Meyer T, Villadsen GE, Wege H, Salati M, Mínguez B, Di Costanzo GG, Roderburg C, Tacke F, Varela M, Galle PR, Alvares-da-Silva MR, Trojan J, Bridgewater J, Cabibbo G, Toso C, Lachenmayer A, Casadei-Gardini A, Toyoda H, Lüdde T, Villani R, Matilla Peña AM, Guedes Leal CR, Ronzoni M, Delgado M, Perelló C, Pascual S, Lledó JL, Argemi J, Basu B, da Fonseca L, Acevedo J, Siebenhüner AR, Braconi C, Meyers BM, Granito A, Sala M, Rodríguez-Lope C, Blaise L, Romero-Gómez M, Piñero F, Gomez D, Mello V, Pinheiro Alves RC, França A, Branco F, Brandi G, Pereira G, Coll S, Guarino M, Benítez C, Anders MM, Bandi JC, Vergara M, Calvo M, Peck-Radosavljevic M, García-Juárez I, Cardinale V, Lozano M, Gambato M, Okolicsanyi S, Morales-Arraez D, Elvevi A, Muñoz AE, Lué A, Iavarone M, Reig M

Assessing the impact of COVID-19 on liver cancer management (CERO-19).

JHEP REPORTS, 2021, 3, 100260-100260 dx.doi.org/10.1016/j.jhepr.2021.100260
0

Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications.

JOURNAL OF HEPATOLOGY, 2020, 73, 328-341 dx.doi.org/10.1016/j.jhep.2020.03.025

Formulari de contacte

About IDIBGI!

menu